A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.
A new article in the February 2018 issue of SLAS Technology describes a new platform that could change the way cancer is diagnosed and treated by automating the isolation of circulating tumor cells (CTCs) directly from cancer patient blood. This article provides unique insight into the development of a commercial system that has the potential to change the standard of care in cancer diagnosis and treatment.
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for limiting muscle, is activated.
Even highly effective individual pain-relieving methods benefit from the use of this odor inhaler by changing pain dynamics and improving pain relief.
1.6 million Americans suffer from IBD. There is no cure for these chronic, life-long conditions. While several effective treatments are available, 40 to 55 percent of patients have no response to current therapies. There is a dire need for new drugs for all patients that are highly safe and effective. Based on research being presented at the Crohn's & Colitis Congress™, we are hopeful that future IBD patients will have new and effective treatment options.
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of malaria parasite that have grown resistant to one of the currently used drugs. This discovery, led by researchers at the University of Cambridge, was aided by Eve, an artificially intelligent 'robot scientist.'
A recent paper published in the journal Molecular Psychiatry explores how a protein named CK2 could play a key role in the formulation of new antidepressants that work more efficiently and faster for more people.
Many drugs work by inhibiting protein enzymes associated with a particular disease. Unfortunately, the same drugs can inhibit protein enzymes unrelated to the disease, resulting in harmful side effects. Computational biologists have a way to identify the features that distinguish one enzyme from similar enzymes. This research has the potential to significantly accelerate drug discovery, allowing scientists to develop more effective drugs, more quickly.
A new original research article in SLAS Discovery presents a fast, sensitive, and robust methodology for screening small molecule inhibitors against CD73/Ecto-5'-Nucleotidase, a promising target for developing anti-cancer drugs.
Pharmaceuticals and other man-made contaminants are forcing fish that live downstream from a typical sewage treatment plant to work at least 30 percent harder just to survive, McMaster researchers have found.